• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国南邦府1990 - 2000年癌症生存率。

Cancer survival in Lampang, Thailand, 1990-2000.

作者信息

Martin N, Pongnikorn S, Patel N, Daoprasert K

机构信息

Lampang Cancer Registry, Lampang Cancer Center, Thailand.

出版信息

IARC Sci Publ. 2011(162):217-26.

PMID:21675426
Abstract

The Lampang cancer registry was established in 1995, with retrospective data collection since 1988. Cancer registration is currently done by passive methods. The registry is contributing data on survival for 40 cancer sites or types registered during 1990-2000. Follow-up has been carried out by passive and active methods with median follow-up ranging from 1-74 months for different cancers. The proportion having a histologically verified diagnosis for various cancers ranged between 30-100%; death certificate only (DCO) cases comprised 0-33%; 67-100% of total registered cases were included for survival analysis. Complete follow-up at five years ranged from 96-100% for different cancers. The 5-year age-standardized relative survival rate was the highest for skin non-melanoma (85%) followed by lip (81%), thyroid (74%), corpus uteri (71%) and penis (71%). The 5-year relative survival by age group showed a fluctuating trend. An overwhelmingly high proportion of cases were diagnosed with a regional spread of disease, ranging from 35-68% for different cancers, and survival was decreasing with increasing extent of disease for most cancers studied.

摘要

南邦癌症登记处成立于1995年,自1988年起进行回顾性数据收集。目前通过被动方法进行癌症登记。该登记处正在提供1990 - 2000年期间登记的40种癌症部位或类型的生存数据。采用被动和主动方法进行随访,不同癌症的中位随访时间为1 - 74个月。各种癌症经组织学确诊的比例在30% - 100%之间;仅死亡证明(DCO)病例占0% - 33%;纳入生存分析的登记病例总数的67% - 100%。不同癌症的五年完全随访率在96% - 100%之间。5年年龄标准化相对生存率最高的是皮肤非黑色素瘤(85%),其次是唇癌(81%)、甲状腺癌(74%)、子宫体癌(71%)和阴茎癌(71%)。按年龄组划分的5年相对生存率呈波动趋势。绝大多数病例被诊断为疾病局部扩散,不同癌症的这一比例在35% - 68%之间,并且对于大多数所研究的癌症,生存率随着疾病范围的扩大而降低。

相似文献

1
Cancer survival in Lampang, Thailand, 1990-2000.泰国南邦府1990 - 2000年癌症生存率。
IARC Sci Publ. 2011(162):217-26.
2
Cancer survival in Chiang Mai, Thailand, 1993-1997.泰国清迈1993 - 1997年癌症生存率。
IARC Sci Publ. 2011(162):199-209.
3
Cancer survival in Songkhla, Thailand, 1990-1999.泰国宋卡1990 - 1999年的癌症生存率。
IARC Sci Publ. 2011(162):227-35.
4
Cancer survival in Khon Kaen, Thailand, 1993-1997.1993 - 1997年泰国孔敬府的癌症生存率
IARC Sci Publ. 2011(162):211-6.
5
Cancer survival in Singapore, 1993-1997.1993 - 1997年新加坡的癌症生存率
IARC Sci Publ. 2011(162):183-98.
6
Cancer survival in Busan, Republic of Korea, 1996-2001.1996 - 2001年韩国釜山的癌症生存率
IARC Sci Publ. 2011(162):155-62.
7
Cancer survival in Izmir, Turkey, 1995-1997.1995 - 1997年土耳其伊兹密尔的癌症生存率
IARC Sci Publ. 2011(162):237-42.
8
Cancer survival in Seoul, Republic of Korea, 1993-1997.1993 - 1997年韩国首尔的癌症生存率
IARC Sci Publ. 2011(162):171-8.
9
Cancer survival in Cuba, 1994-1995.1994 - 1995年古巴的癌症生存率
IARC Sci Publ. 2011(162):89-95.
10
Cancer survival in Mumbai (Bombay), India, 1992-1999.1992 - 1999年印度孟买(旧称: Bombay)的癌症生存率。
IARC Sci Publ. 2011(162):133-42.

引用本文的文献

1
Five-year survival rate of kidney cancer (localized renal cell carcinoma) in the Asia: A systematic review and meta-analysis.亚洲肾癌(局限性肾细胞癌)的五年生存率:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Aug 22;104(34):e43867. doi: 10.1097/MD.0000000000043867.
2
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.亚洲国家肝细胞癌的生存率:一项系统评价与荟萃分析。
EXCLI J. 2020 Jan 13;19:108-130. doi: 10.17179/excli2019-1842. eCollection 2020.
3
Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis.
亚洲国家前列腺癌的生存率:一项系统评价与荟萃分析。
Ann Glob Health. 2020 Jan 2;86(1):2. doi: 10.5334/aogh.2607.